Deals

The latest pharma deals — mergers, acquisitions, licensing agreements, and partnerships shaping the business of drug development worldwide.

A concept image to illustrate mental health medications Models of a pink brain and two white pills which are about the size
Biotech

Jazz's Actio buyout gives rise to Setara with $90M series A

The spinout's lead asset targets a rare inherited neuropathy, with potential applications in the much larger overactive bladder population.
Michael Gibney Oct 30, 2026 6:30am
Biomarin

BioMarin inks up to $475M deal to challenge Fabry ERT incumbents

Oct 29, 2026 10:13am
Astellas

Astellas makes $1.3B bet on Audax’s preclinical IL-12 program

Oct 28, 2026 5:37am
Weight loss pills Obesity treatment

Why Corxel picked SPAC route to take obesity biotech public

Oct 27, 2026 6:00am
Gilead

Gilead to buy PepStar’s oral IL-23 drug for $1.3B upfront

Oct 23, 2026 9:00am
lightning

Bolt strikes Prana reverse merger alongside $120M financing

Oct 23, 2026 9:00am